[ad_1] FILE PHOTO: Johnson & Johnson building shown in Irvine, California Thomson Reuters (Reuters) – Johnson & Johnson said Tuesday that its star drug, Stelara, was effective in treating chronic intestinal disease …
Read More »Single dose of J & J's Stelara shows treatment effect in late-stage advanced cancer study – Johnson & Johnson (NYSE: JNJ)
[ad_1] Results from a Phase 3 clinical trial, UNIFI, on Janssen Pharmaceuticals (NYSE: JNJ) STELARA (ustekinumab) from Johnson & Johnson (NYSE: JNJ) in adult patients with moderate to severe ulcerative colitis who …
Read More »